Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Rallybio (RLYB) Shares Issued (2024 - 2025)

Rallybio (RLYB) has disclosed Shares Issued for 2 consecutive years, with -$10000.0 as the latest value for Q3 2025.

  • Quarterly Shares Issued rose 99.81% to -$10000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$10000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $5.4 million for FY2024, N/A changed from the prior year.
  • Shares Issued hit -$10000.0 in Q3 2025 for Rallybio, down from $5.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $5.4 million in Q4 2024 to a low of -$5.4 million in Q3 2024.